Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Best Practices for Sentinel Events: What Every Healthcare Organization Needs to Know

In any healthcare environment, patient safety is always top of mind. Each staff member is responsible for their own actions. Administrators are too, especially when those actions include reacting to a safety concern raised by an employee. To ensure that healthcare organizations have a high-reliability culture, the Joint Commission Center for Transforming Healthcare published a…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In any healthcare environment, patient safety is always top of mind. Each staff member is responsible for their own actions. Administrators are too, especially when those actions include reacting to a safety concern raised by an employee. To ensure that healthcare organizations have a high-reliability culture, the Joint Commission Center for Transforming Healthcare published a report, “Sentinel Event Alert 60: Developing a Reporting Culture: Learning from Close Calls and Hazardous Conditions.” 1 The Joint Commission issued this report to encourage a reporting culture where swift action is taken to remedy unsafe conditions.

What Is a Sentinel Event?

The Joint Commission’s mission is “to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value.2 The Joint Commission defines a sentinel event as an unanticipated event in a healthcare setting resulting in death or serious injury, physical or psychological, not related to natural causes or the patient’s illness. The Joint Commission identifies sentinel events in its accreditation policies to assist with root cause analysis and the development of new preventive measures. Accredited organizations are required to define sentinel events for their own care system and implement monitoring procedures and a process for root cause analysis.

Standards Must Be in Place to Respond to a Sentinel Event

Should a sentinel event occur, any accredited healthcare organization must have a process to respond. Causal factors need to be analyzed, focusing on the system holistically. An “action plan” should be put in place for potential improvements to decrease the chance of the event happening again. The Joint Commission encourages organizations to report any sentinel event, but it’s not required. The organization will have to create root cause analysis and an action plan within 45 days of the event. You can also consult with The Joint Commission on initiating the root cause analysis and action plan. If the event was due to a medical device defect, then an organization must report the incident to the Food and Drug Administration within 10 days.

There are benefits to reporting the event that can be of help to other organizations. A reported event is added to the database which other facilities have access to, providing vital information that could help to prevent a similar event from occurring at their organizations.

Sentinel Event Standards

Within the Performance Improvement and Leadership chapters of the accreditation manual, there are standards for the expectations regarding the internal identification and management of sentinel events.

With the organization’s definition of the sentinel event, it must include the specific events that would be reviewed under the Sentinel Event Policy. Following a sentinel event, the organization must begin its investigation by determining root cause analysis, then develop its plan and identify ways to reduce future risk. After the standards are implemented, they are closely monitored to ascertain their viability.

Reporting Is a Key Element of Sentinel Event Management

In order to manage sentinel events, your culture must be one that has adopted reporting. Only with reporting will you be able to truly understand the causes of a particular event and prevent similar events from happening again. The four Es of a Reporting Culture include:3

  1. Establish trust: there can be no culture of reporting without trust; leaders must show their continued commitment to safety and governance should support this as well.
  2. Encourage reporting: this means that reporting is accessible by all staff, easy to use, and delivers data analysis in a timely fashion. Encouragement also means that staff receives feedback so that they know the action is being taken when reports are made. The organization should also define the types of events that should be reported.
  3. Eliminate fear of punishment: ensure that your staff knows that there is no retaliation or punishment for reporting safety concerns. All staff, regardless of position, should be held to the same standards.
  4. Examine errors: refer to the data compiled and use it to identify the highest risk situations and take action. Data is also used to celebrate staff when they are successful. Data helps strengthen the safety program and the culture of reporting.

The Joint Commission also offers resources and support so you can continue to enhance a culture of reporting within your organization.4

https://www.alimed.com/_resources/common/userfiles/file/infographics/AliMed_ReportingCulture-Infographic.pdf

References

  1. https://www.jointcommission.org/
  2. https://www.jointcommission.org
  3. https://www.jointcommission.org/
  4. https://www.jointcommission.org/

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512